LONDON-- Lonza Group AG confirmed Monday that it was in talks to buy New Jersey drug-capsule maker Capsugel from private-equity firm KKR & Co., a deal valued at more than $5 billion. The Swiss pharmaceutical firm said it had expressed a "strong interest" in Capsugel as it would fit with its health-care strategy.
